Business
Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment - Investor's Business Daily
Over the course of a year, Amgen's MariTide helped patients lose about 20% of their body weight.
By: Investor's Business Daily
- Nov 28 2024
- 0
- 0 Views
Amgen (AMGN) stock tumbled Tuesday after its highly anticipated weight-loss drug met Wall Street's expectations, but didn't beat out Eli Lilly's (LLY) blockbuster, Zepbound.
XNOW PLAYINGThe Weight-L… [+6442 chars]